SPIRIVA Side Effects

7023543-3 | Oropharyngeal Pain
on Sep 30, 2010 Female patient from UNITED STATES , 54 years of age, was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: oropharyngeal pain. Spiriva dosage: 18mcg Inhaled Once Daily Inhal.

7020900-6 | Dyspnoea
Patient was taking Spiriva (View Usage). Patient had the following side effects: dyspnoea on Sep 27, 2010 from Additional patient health information: Female patient , 44 years of age, was diagnosed with asthma (What is asthma?) and. Spiriva dosage: .

7020094-7 | Constipation
Adverse event was reported on Sep 21, 2010 by a Female patient taking Spiriva (View Usage) (Dosage: 18 Mcg) was diagnosed with emphysema, blood cholesterol increased, gastrooesophageal reflux disease, osteoporosis (What is osteoporosis?) and. Location: , 79 years of age, After Spiriva was administered, patient had the following side effects: constipation (What is constipation?). During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), PROTONIX (View Protonix Review and Protonix Label ), CALCIUM (View Calcium Review and Calcium Label ), VITAMINS (View Vitamins Review and Vitamins Label ).

7019246-1 | Arthropathy, Colitis, Rash, Skin Discolouration, Skin Disorder, Systemic Lupus Erythematosus
on Jul 22, 2010 Female patient from , weighting 242.0 lb, was diagnosed with blood cholesterol increased, colitis, pain (What is pain?), thyroid disorder, hypertension and was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: arthropathy, colitis, rash (What is rash?), skin discolouration, skin disorder, systemic lupus erythematosus. Spiriva dosage: . During the same period patient was treated with LIPITOR (10 Mg) (View Lipitor Review and Lipitor Label ), AZULFIDINE (View Azulfidine Review and Azulfidine Label ), ELAVIL (View Elavil Review and Elavil Label ), TICLID (500 Mg) (View Ticlid Review and Ticlid Label ), SYNTHROID (2.5 Mg) (View Synthroid Review and Synthroid Label ), NORVASC (View Norvasc Review and Norvasc Label ).


7014389-0 | Condition Aggravated, Impaired Work Ability
on Sep 15, 2010 Female patient from , weighting 300.0 lb, was diagnosed with dyspnoea, neuropathy peripheral, arthritis (What is arthritis?) and was treated with Spiriva (View Usage). Patient had the following side effects: condition aggravated, impaired work ability. Spiriva dosage: 36 Mcg. During the same period patient was treated with LYRICA (300 Mg) (View Lyrica Review and Lyrica Label ), CELEBREX (400 Mg) (View Celebrex Review and Celebrex Label ), LISINOPRIL (20 Mg) (View Lisinopril Review and Lisinopril Label ), VENTOLIN (2 Puf) (View Ventolin Review and Ventolin Label ), SIMVASTATIN (20 Mg) (View Simvastatin Review and Simvastatin Label ), METFORMIN HCL (2000 Mg) (View Metformin Hcl Review and Metformin Hcl Label ), LASIX (80 Mg) (View Lasix Review and Lasix Label ).

7013874-5 | Abdominal Discomfort, Abdominal Pain Upper, Dyspepsia, Gastritis, Gastrooesophageal Reflux Disease, Vision Blurred, Vitamin D Deficiency
Patient was taking Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: abdominal discomfort, abdominal pain upper, dyspepsia, gastritis, gastrooesophageal reflux disease, vision blurred, vitamin d deficiency on Sep 17, 2010 from Additional patient health information: Female patient , weighting 97.00 lb, was diagnosed with bronchitis chronic, vitamin d deficiency and. Spiriva dosage: . During the same period patient was treated with PROTONIX (40 Mg) (View Protonix Review and Protonix Label ), VITAMIN D SUPPLEMENTS (View Vitamin D Supplements Review and Vitamin D Supplements Label ).

7013358-4 | Discomfort, Dry Eye, Dry Mouth, Eye Pain, Fatigue, Insomnia, Lacrimation Increased, Micturition Urgency
Adverse event was reported on Sep 03, 2010 by a Female patient taking Spiriva (View Usage) (Dosage: 18 Mcg) was diagnosed with chronic obstructive pulmonary disease, dyspnoea, hypertension and. Location: , weighting 190.0 lb, Patient experienced the following unwanted or unexpected effects: discomfort, dry eye, dry mouth, eye pain, fatigue, insomnia, lacrimation increased, micturition urgency. During the same period patient was treated with SPIRONOLACTONE (25 Mg) (View Spironolactone Review and Spironolactone Label ), TOPROL XL (25 Mg) (View Toprol-xl Review and Toprol-xl Label ), SIMVASTATIN (20 Mg) (View Simvastatin Review and Simvastatin Label ), COUMADIN (2 Mg) (View Coumadin Review and Coumadin Label ), METFORMIN (1500 Mg) (View Metformin Review and Metformin Label ), FOSAMAX (1 Per Week) (View Fosamax Review and Fosamax Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ).

7010352-4 | Device Failure, Dry Mouth, Gingivitis, Stomatitis, Weight Decreased
on Sep 10, 2010 Male patient from , 82 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient had the following side effects: device failure, dry mouth, gingivitis, stomatitis, weight decreased. Spiriva dosage: 18 Mcg.

7009429-9 | Erythema, Pruritus, Weight Increased
on Sep 10, 2010 Female patient from , 70 years of age, was diagnosed with chronic obstructive pulmonary disease, gastrooesophageal reflux disease and was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: erythema, pruritus, weight increased. Spiriva dosage: 18 Mcg. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), PREVACID (2 In One Day) (View Prevacid Review and Prevacid Label ), VASOTEC (View Vasotec Review and Vasotec Label ), FLUTINASONE PROPIONATE (View Flutinasone Propionate Review and Flutinasone Propionate Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), LORATADINE (View Loratadine Review and Loratadine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

7009362-2 | Weight Increased
Patient was taking Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: weight increased on Sep 13, 2010 from Additional patient health information: Female patient , 73 years of age, was diagnosed with chronic obstructive pulmonary disease, emphysema, anxiety (What is anxiety?), mood altered, hypertension, ulcer (What is ulcer?) and. Spiriva dosage: 18 Mcg. During the same period patient was treated with ATIVAN (View Ativan Review and Ativan Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), PAXIL (View Paxil Review and Paxil Label ).

7008915-5 | Upper Limb Fracture
Adverse event was reported on Sep 10, 2010 by a Female patient taking Spiriva (View Usage) (Dosage: ) was diagnosed with chronic obstructive pulmonary disease, emphysema and. Location: , 62 years of age, Patient had the following side effects: upper limb fracture. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), EFFEXOR (View Effexor Review and Effexor Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

7008459-0 | Condition Aggravated
on Sep 13, 2010 Male patient from , 70 years of age, was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: condition aggravated. Spiriva dosage: .

7007966-4 | Arthritis, Cataract, Dyspnoea, Iritis, Oedema Peripheral
on Sep 10, 2010 Female patient from , 75 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), cataract (What is cataract?), dyspnoea, iritis, oedema peripheral. Spiriva dosage: .

7007126-7 | Dyspnoea, Lymphoma
Patient was taking Spiriva (View Usage). Patient had the following side effects: dyspnoea, lymphoma (What is lymphoma?) on Sep 16, 2010 from Additional patient health information: Male patient , 72 years of age, was diagnosed with chronic obstructive pulmonary disease, hypertension, dyspnoea, neuropathy peripheral, multiple allergies, prophylaxis and. Spiriva dosage: 18 Mcg. During the same period patient was treated with ATENOLOL (100 Mg) (View Atenolol Review and Atenolol Label ), PROAIR HFA (View Proair Hfa Review and Proair Hfa Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), PREDNISONE (5 Mg) (View Prednisone Review and Prednisone Label ), GABAPENTIN (1800 Mg) (View Gabapentin Review and Gabapentin Label ), CLARITIN (View Claritin Review and Claritin Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ).

7007124-3 | Cough
Adverse event was reported on Sep 15, 2010 by a Female patient taking Spiriva (View Usage) (Dosage: 18 Mcg) was diagnosed with chronic obstructive pulmonary disease and. Location: , 29 years of age, After Spiriva was administered, patient had the following side effects: cough.

7007085-7 | Cardiac Failure Congestive
on Sep 16, 2010 Female patient from , 75 years of age, was diagnosed with chronic obstructive pulmonary disease, diabetes mellitus and was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive. Spiriva dosage: 18 Mcg. During the same period patient was treated with AVANDIA (View Avandia Review and Avandia Label ). Patient was hospitalized.

7002781-X | Angle Closure Glaucoma, Erythema, Pruritus
on Sep 13, 2010 Male patient from , 79 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient had the following side effects: angle closure glaucoma, erythema, pruritus. Spiriva dosage: 18 Mcg.

7002020-X | Bronchiectasis, Cough
Patient was taking Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: bronchiectasis, cough on Sep 14, 2010 from Additional patient health information: Female patient , 83 years of age, was diagnosed with emphysema, bronchitis chronic, arrhythmia (What is arrhythmia?), blood cholesterol increased, gastrooesophageal reflux disease and. Spiriva dosage: 18 Mcg. During the same period patient was treated with MULTAQ (800 Mg) (View Multaq Review and Multaq Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6988388-9 | Dizziness, Dry Mouth, Nausea
Adverse event was reported on Sep 10, 2010 by a Male patient taking Spiriva (View Usage) (Dosage: ) was diagnosed with chronic obstructive pulmonary disease, bronchitis (What is bronchitis?) and. Location: , weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), dry mouth, nausea (What is nausea?). During the same period patient was treated with CHANTIX (0.5 Mg) (View Chantix Review and Chantix Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6983472-8 | Capsule Issue, Incorrect Dose Administered, Lung Disorder, Medical Device Complication, Product Quality Issue
on Sep 14, 2010 Female patient from UNITED STATES , 91 years of age, was diagnosed with bronchospasm, respiratory disorder and was treated with Spiriva (View Usage). Patient had the following side effects: capsule issue, incorrect dose administered, lung disorder, medical device complication, product quality issue. Spiriva dosage: .

6981600-1 | Interstitial Lung Disease
on Sep 10, 2010 Female patient from , 80 years of age, was diagnosed with emphysema, insomnia and was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: interstitial lung disease. Spiriva dosage: 5 Mcg. During the same period patient was treated with LENDORMIN (1df) (View Lendormin Review and Lendormin Label ), FAMOTIDINE (30 Mg) (View Famotidine Review and Famotidine Label ). Patient was hospitalized and became disabled.

6980777-1 | Hypersensitivity
Patient was taking Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity on Sep 10, 2010 from UNITED STATES Additional patient health information: Male patient , 79 years of age, weighting 153.0 lb, was diagnosed with computerised tomogram, hypoxia and. Spiriva dosage: 18 Mcg Daily (30x) Mouth Inhale Total 4 Times.

6980589-9 | Stevens-johnson Syndrome
Adverse event was reported on Sep 08, 2010 by a Male patient taking Spiriva (View Usage) (Dosage: 18 Mcg) was diagnosed with chronic obstructive pulmonary disease and. Location: , 64 years of age, Patient had the following side effects: stevens-johnson syndrome. During the same period patient was treated with BUDESONIDE (View Budesonide Review and Budesonide Label ), FORMOTEROL FUMARATE (View Formoterol Fumarate Review and Formoterol Fumarate Label ).

6980370-0 | Blood Pressure Increased, Nausea, Skin Discolouration
on Sep 08, 2010 Male patient from , 88 years of age, was diagnosed with chronic obstructive pulmonary disease, hypertension and was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: blood pressure increased, nausea (What is nausea?), skin discolouration. Spiriva dosage: 18 Mcg. During the same period patient was treated with ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), IMDUR (View Imdur Review and Imdur Label ), ASPIRIN (81 Mg) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6980145-2 | Bronchitis, Dry Mouth, Nasopharyngitis, Pneumonia, Urinary Retention
on Sep 01, 2010 Female patient from , weighting 102.0 lb, was diagnosed with asthma (What is asthma?), chronic obstructive pulmonary disease, bronchitis chronic, pneumonia (What is pneumonia?), blood cholesterol increased and was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), dry mouth, nasopharyngitis, pneumonia (What is pneumonia?), urinary retention. Spiriva dosage: 18 Mcg. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), NASONEX (View Nasonex Review and Nasonex Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ).

6978296-1 | Dry Mouth, Gingival Erosion
Patient was taking Spiriva (View Usage). Patient had the following side effects: dry mouth, gingival erosion on Aug 31, 2010 from Additional patient health information: Male patient , 61 years of age, was diagnosed with pneumonia (What is pneumonia?), chronic obstructive pulmonary disease and. Spiriva dosage: . During the same period patient was treated with BROVANA (View Brovana Review and Brovana Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ).

6978291-2 | Chronic Obstructive Pulmonary Disease, Dyspnoea
Adverse event was reported on Sep 01, 2010 by a Male patient taking Spiriva (View Usage) (Dosage: ) was diagnosed with chronic obstructive pulmonary disease and. Location: , 66 years of age, weighting 405.0 lb, After Spiriva was administered, patient had the following side effects: chronic obstructive pulmonary disease, dyspnoea.

6974193-6 | Increased Upper Airway Secretion, Lung Disorder
on Aug 31, 2010 Female patient from , 68 years of age, was diagnosed with chronic obstructive pulmonary disease, nerve injury, pain (What is pain?), anxiety (What is anxiety?) and was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: increased upper airway secretion, lung disorder. Spiriva dosage: 18 Mcg. During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), ROBINUL (View Robinul Review and Robinul Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

6973514-8 | Barrett's Oesophagus, Dysphonia, Oropharyngeal Pain, Sinusitis
on Aug 30, 2010 Female patient from , 66 years of age, was diagnosed with emphysema and was treated with Spiriva (View Usage). Patient had the following side effects: barrett's oesophagus, dysphonia, oropharyngeal pain, sinusitis (What is sinusitis?). Spiriva dosage: 18 Mcg.

6972508-6 | Fatigue
Patient was taking Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: fatigue on Aug 27, 2010 from Additional patient health information: Female patient , 84 years of age, weighting 120.0 lb, was diagnosed with emphysema, chronic obstructive pulmonary disease and. Spiriva dosage: 18 Mcg. During the same period patient was treated with VENTOLIN (1 Puf) (View Ventolin Review and Ventolin Label ), METOPROLOL XL (View Metoprolol Xl Review and Metoprolol Xl Label ), ASMANEX TWISTHALER (View Asmanex Twisthaler Review and Asmanex Twisthaler Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), LANSOPRAZOLE (30 Mg) (View Lansoprazole Review and Lansoprazole Label ).

6971278-5 | Anaemia, Cerebrovascular Accident, Chronic Obstructive Pulmonary Disease, Fibromyalgia, Headache, Impaired Driving Ability, Memory Impairment, Mobility Decreased, Speech Disorder
Adverse event was reported on Sep 01, 2010 by a Female patient taking Spiriva (View Usage) (Dosage: 18 Mcg) was diagnosed with chronic obstructive pulmonary disease, fibromyalgia, cerebrovascular accident, sleep disorder (What is sleep disorder?), headache (What is headache?), abdominal discomfort, hypertension and. Location: , weighting 120.0 lb, Patient experienced the following unwanted or unexpected effects: anaemia, cerebrovascular accident, chronic obstructive pulmonary disease, fibromyalgia, headache (What is headache?), impaired driving ability, memory impairment, mobility decreased, speech disorder. During the same period patient was treated with LYRICA (150 Mg) (View Lyrica Review and Lyrica Label ), LIPITOR (20 Mg) (View Lipitor Review and Lipitor Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), PROTONIX (View Protonix Review and Protonix Label ), PINDOLOL (View Pindolol Review and Pindolol Label ). Patient was hospitalized and became disabled.

6971177-9 | Dyspnoea
on Aug 27, 2010 Male patient from , 75 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient had the following side effects: dyspnoea. Spiriva dosage: 18 Mcg.

6969648-4 | Diabetes Mellitus, Dry Eye, Dry Mouth, Erythema, Hypersensitivity, Pneumonia, Skin Discolouration, Thrombocytopenia
on Aug 31, 2010 Female patient from , 60 years of age, was diagnosed with chronic obstructive pulmonary disease, bronchitis chronic, hypertension, fluid retention, anxiety (What is anxiety?), depression (What is depression?), ear pain and was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: diabetes mellitus, dry eye, dry mouth, erythema, hypersensitivity, pneumonia (What is pneumonia?), skin discolouration, thrombocytopenia. Spiriva dosage: 18 Mcg. During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), LISINOPRIL (20 Mg) (View Lisinopril Review and Lisinopril Label ), CHLORTHALIDONE (25 Mg) (View Chlorthalidone Review and Chlorthalidone Label ), XANAX (0.5 Mg) (View Xanax Review and Xanax Label ), PROZAC (60 Mg) (View Prozac Review and Prozac Label ), NEOMYCIN/POLYMYXIN/HYDROCODONE (60 Mg) (View Neomycin/polymyxin/hydrocodone Review and Neomycin/polymyxin/hydrocodone Label ). Patient was hospitalized.

6967434-2 | Upper Limb Fracture
Patient was taking Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: upper limb fracture on Aug 24, 2010 from Additional patient health information: Female patient , 62 years of age, was diagnosed with chronic obstructive pulmonary disease, emphysema and. Spiriva dosage: . During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), EFFEXOR (View Effexor Review and Effexor Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6966072-5 | Cough, Surgery
Adverse event was reported on Sep 01, 2010 by a Female patient taking Spiriva (View Usage) (Dosage: 18 Mcg) . Location: , 29 years of age, Patient had the following side effects: cough, surgery (What is surgery?).

6964978-4 | Cataract, Intraocular Pressure Increased
on Aug 24, 2010 Female patient from , weighting 120.0 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: cataract (What is cataract?), intraocular pressure increased. Spiriva dosage: . During the same period patient was treated with XALATAN (View Xalatan Review and Xalatan Label ), PROAIR HFA (View Proair Hfa Review and Proair Hfa Label ).

6963079-9 | Diabetes Mellitus, Dry Eye, Dry Mouth, Erythema, Hypersensitivity, Pneumonia, Skin Discolouration, Thrombocytopenia
on Aug 31, 2010 Female patient from , 60 years of age, was diagnosed with chronic obstructive pulmonary disease, bronchitis chronic, hypertension, fluid retention, anxiety (What is anxiety?), depression (What is depression?), ear pain and was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus, dry eye, dry mouth, erythema, hypersensitivity, pneumonia (What is pneumonia?), skin discolouration, thrombocytopenia. Spiriva dosage: 18 Mcg. During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), LISINOPRIL (20 Mg) (View Lisinopril Review and Lisinopril Label ), CHLORTHALIDONE (25 Mg) (View Chlorthalidone Review and Chlorthalidone Label ), XANAX (0.5 Mg) (View Xanax Review and Xanax Label ), PROZAC (60 Mg) (View Prozac Review and Prozac Label ), NEOMYCIN/POLYMYXIN/HYDROCODONE (60 Mg) (View Neomycin/polymyxin/hydrocodone Review and Neomycin/polymyxin/hydrocodone Label ). Patient was hospitalized.

6962668-5 | Dyspnoea
Patient was taking Spiriva (View Usage). Patient had the following side effects: dyspnoea on Aug 27, 2010 from Additional patient health information: Female patient , weighting 110.0 lb, was diagnosed with chronic obstructive pulmonary disease, emphysema, hypertension, anxiety (What is anxiety?), dry eye and. Spiriva dosage: 18 Mcg. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ATENOLOL (100 Mg) (View Atenolol Review and Atenolol Label ), LISINOPRIL (40 Mg) (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), THERATEARS (3000 Mg) (View Theratears Review and Theratears Label ), FLAX SEED OIL (View Flax Seed Oil Review and Flax Seed Oil Label ).

6959364-7 | Anuria, Dry Mouth, Prostatomegaly, Stomatitis
Adverse event was reported on Aug 31, 2010 by a Male patient taking Spiriva (View Usage) (Dosage: ) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 75 years of age, weighting 150.0 lb, After Spiriva was administered, patient had the following side effects: anuria, dry mouth, prostatomegaly, stomatitis.

6957724-1 | Dry Mouth, Dysphonia, Oropharyngeal Discomfort, Vocal Cord Polyp
on Aug 26, 2010 Male patient from , 67 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: dry mouth, dysphonia, oropharyngeal discomfort, vocal cord polyp. Spiriva dosage: 18 Mcg. During the same period patient was treated with CLARITHROMYCIN (200 Mg) (View Clarithromycin Review and Clarithromycin Label ), DASEN (10 Mg) (View Dasen Review and Dasen Label ), JUVELA N (100 Mg) (View Juvela N Review and Juvela N Label ).

6957034-2 | Product Quality Issue
on Aug 27, 2010 Female patient from UNITED STATES , 61 years of age, weighting 138.2 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient had the following side effects: product quality issue. Spiriva dosage: Spiriva 18 Mcg Once Daily Inhaled.

6955971-6 | Erythema, Pruritus, Weight Increased
Patient was taking Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: erythema, pruritus, weight increased on Aug 17, 2010 from Additional patient health information: Female patient , 70 years of age, was diagnosed with chronic obstructive pulmonary disease, gastrooesophageal reflux disease and. Spiriva dosage: 18 Mcg. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), PREVACID (2 In One Day) (View Prevacid Review and Prevacid Label ), VASOTEC (View Vasotec Review and Vasotec Label ).

6955332-X | Emphysema, Hypoxia
Adverse event was reported on Aug 25, 2010 by a Female patient taking Spiriva (View Usage) (Dosage: 18 Mcg) was diagnosed with chronic obstructive pulmonary disease, emphysema and. Location: , 55 years of age, Patient experienced the following unwanted or unexpected effects: emphysema, hypoxia. Patient was hospitalized.

6955248-9 | Arthritis, Dysuria, Eye Pain, Feeling Jittery, Nausea, Pollakiuria, Urine Flow Decreased, Vision Blurred
on Aug 16, 2010 Female patient from , 63 years of age, was diagnosed with fibrosis, emphysema, diabetes mellitus, arthropathy, prophylaxis and was treated with Spiriva (View Usage). Patient had the following side effects: arthritis (What is arthritis?), dysuria, eye pain, feeling jittery, nausea (What is nausea?), pollakiuria, urine flow decreased, vision blurred. Spiriva dosage: 18 Mcg. During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ), CELEBREX (View Celebrex Review and Celebrex Label ), NEXIUM (View Nexium Review and Nexium Label ).

6954907-1 | Abdominal Pain Upper, Constipation
on Aug 13, 2010 Male patient from , weighting 260.0 lb, was diagnosed with emphysema, blood cholesterol increased, hypertension and was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: abdominal pain upper, constipation (What is constipation?). Spiriva dosage: 18 Mcg. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ).

6945300-6 | Anxiety
Patient was taking Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?) on Aug 10, 2010 from Additional patient health information: Female patient , 75 years of age, . Spiriva dosage: 18 Mcg.

6942476-1 | Dyspnoea
Adverse event was reported on Aug 11, 2010 by a Male patient taking Spiriva (View Usage) (Dosage: 18 Mcg) was diagnosed with chronic obstructive pulmonary disease and. Location: , 68 years of age, Patient had the following side effects: dyspnoea. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6941107-4 | Diabetes Mellitus, Dry Eye, Dry Mouth, Ear Pain, Erythema, Hypersensitivity, Pneumonia, Skin Discolouration
on Aug 24, 2010 Female patient from , 60 years of age, was diagnosed with chronic obstructive pulmonary disease, bronchitis chronic, hypertension, fluid retention, anxiety (What is anxiety?), depression (What is depression?), ear pain and was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: diabetes mellitus, dry eye, dry mouth, ear pain, erythema, hypersensitivity, pneumonia (What is pneumonia?), skin discolouration. Spiriva dosage: 18 Mcg. During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), LISINOPRIL (20 Mg) (View Lisinopril Review and Lisinopril Label ), CHLORTHALIDONE (25 Mg) (View Chlorthalidone Review and Chlorthalidone Label ), XANAX (0.5 Mg) (View Xanax Review and Xanax Label ), PROZAC (60 Mg) (View Prozac Review and Prozac Label ), NEOMYCIN/POLYMYXIN/HYDROCODONE (60 Mg) (View Neomycin/polymyxin/hydrocodone Review and Neomycin/polymyxin/hydrocodone Label ). Patient was hospitalized.

6940582-9 | Dyspnoea, Infarction, Left Ventricular Dysfunction, Myocardial Ischaemia, Weight Increased
on Aug 16, 2010 Female patient from , 76 years of age, weighting 133.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, infarction, left ventricular dysfunction, myocardial ischaemia, weight increased. Spiriva dosage: . During the same period patient was treated with ARIMIDEX (1 Mg) (View Arimidex Review and Arimidex Label ), FORTEO (View Forteo Review and Forteo Label ), NORVASC (View Norvasc Review and Norvasc Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), CHANTIX (View Chantix Review and Chantix Label ), COREG (View Coreg Review and Coreg Label ), IMDUR (View Imdur Review and Imdur Label ). Patient was hospitalized.

6940114-5 | Conjunctivitis
Patient was taking Spiriva (View Usage). Patient had the following side effects: conjunctivitis on Aug 23, 2010 from Additional patient health information: Female patient , weighting 100.1 lb, was diagnosed with emphysema, bronchitis chronic, chronic obstructive pulmonary disease and. Spiriva dosage: 5 Mcg. During the same period patient was treated with PROTECADIN (2 Df) (View Protecadin Review and Protecadin Label ), MUCODYNE (2 Df) (View Mucodyne Review and Mucodyne Label ), CLARITHROMYCIN (2 Df) (View Clarithromycin Review and Clarithromycin Label ), THEO DUR (1 Df) (View Theo-dur Review and Theo-dur Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ).